naming Maugham as co-respondent. The suit attracted large amounts of publicity that he had previously tried to avoid. Syrie never contested Henry's custody of their child, Henry. In 1910, Wellcome became a British subject. In 1928, he was made an Honorary Vice-President of the Society for Nautical Research. He was appointed a Knight Bachelor in the 1932 Birthday Honours. In 1932, he was made an Honorary Fellow of the Royal College of Surgeons of England. He died of pneumonia in The London Clinic in 1936, aged 82, after an operation. On his death, the Wellcome Trust was established. Legacy In his will, Wellcome vested the entire share capital of his company in individual trustees, who were charged with spending the income to further human and animal health. The Wellcome Trust is now one of the world's largest private biomedical charities. The first biography of Wellcome was commissioned by the Wellcome Trust in 1939, by A. W. Haggis, a member of staff at the Historical Medicine Museum Wellcome had established. The trustees, however, were dissatisfied with the final draft of 1942, and the biography was never published, although the drafts are freely available for consultation at the Wellcome Library. A biography of Wellcome was written by Robert Rhodes James and published in 1994. In 2009, An Infinity of Things: How Sir Henry Wellcome Collected the World, written by Frances Larson, was published by Oxford University Press, after both Wellcome's personal and business papers had been catalogued. The Wellcome Trust After Wellcome's death, the income from the foundation, initially via dividends, later via more tax efficient deeds of covenant, was used to fund the Wellcome Trust, providing endowments for pharmacology departments to educate and train the researchers of the future. After changes in UK charity law the foundation was sold to GSK and the receipts invested in a broad ranging portfolio. The trust then became the largest charity in the UK, providing funding for focus areas such as biomedical science, technology transfer, public engagement and bioethics. Grants and fellowships are available to recipients with goals of translating research into usable health products. The trust currently spends over $600 million a year in medical research training. In 1955, the Burroughs Wellcome Fund (BWF) was established as the U.S. branch of the Wellcome pharmaceutical enterprise; in 1993, a $400 million gift from the Wellcome Trust enabled BWF to become fully independent from the company,